293 related articles for article (PubMed ID: 15105449)
21. Upgrade of high-risk breast lesions detected on mammography in the Breast Cancer Surveillance Consortium.
Menes TS; Rosenberg R; Balch S; Jaffer S; Kerlikowske K; Miglioretti DL
Am J Surg; 2014 Jan; 207(1):24-31. PubMed ID: 24112677
[TBL] [Abstract][Full Text] [Related]
22. Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsy.
Tocino I; Garcia BM; Carter D
Ann Surg Oncol; 1996 Sep; 3(5):483-8. PubMed ID: 8876891
[TBL] [Abstract][Full Text] [Related]
23. Atypical hyperplastic lesions of the female breast. A long-term follow-up study.
Page DL; Dupont WD; Rogers LW; Rados MS
Cancer; 1985 Jun; 55(11):2698-708. PubMed ID: 2986821
[TBL] [Abstract][Full Text] [Related]
24. MR imaging of ductal carcinoma in situ.
Orel SG; Mendonca MH; Reynolds C; Schnall MD; Solin LJ; Sullivan DC
Radiology; 1997 Feb; 202(2):413-20. PubMed ID: 9015067
[TBL] [Abstract][Full Text] [Related]
25. The lobular neoplasia enigma: management and prognosis in a long follow-up case series.
Metovic J; Abate SO; Borella F; Vissio E; Bertero L; Mariscotti G; Durando M; Senetta R; Ala A; Benedetto C; Sapino A; Cassoni P; Castellano I
World J Surg Oncol; 2021 Mar; 19(1):80. PubMed ID: 33736652
[TBL] [Abstract][Full Text] [Related]
26. Lobular carcinoma in situ: mammographic-pathologic correlation of results of needle-directed biopsy.
Sonnenfeld MR; Frenna TH; Weidner N; Meyer JE
Radiology; 1991 Nov; 181(2):363-7. PubMed ID: 1924773
[TBL] [Abstract][Full Text] [Related]
27. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions.
Dahlstrom JE; Sutton S; Jain S
Histopathology; 1996 Jun; 28(6):537-41. PubMed ID: 8803597
[TBL] [Abstract][Full Text] [Related]
28. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.
Hartmann LC; Radisky DC; Frost MH; Santen RJ; Vierkant RA; Benetti LL; Tarabishy Y; Ghosh K; Visscher DW; Degnim AC
Cancer Prev Res (Phila); 2014 Feb; 7(2):211-7. PubMed ID: 24480577
[TBL] [Abstract][Full Text] [Related]
29. Intraductal carcinoma. Analysis of presentation, pathologic findings, and outcome of disease.
Schuh ME; Nemoto T; Penetrante RB; Rosner D; Dao TL
Arch Surg; 1986 Nov; 121(11):1303-7. PubMed ID: 3022676
[TBL] [Abstract][Full Text] [Related]
30. Analysis of cancers not diagnosed at stereotactic core breast biopsy.
Liberman L; Dershaw DD; Glassman JR; Abramson AF; Morris EA; LaTrenta LR; Rosen PP
Radiology; 1997 Apr; 203(1):151-7. PubMed ID: 9122384
[TBL] [Abstract][Full Text] [Related]
31. Noninvasive breast cancer.
Rebner M; Raju U
Radiology; 1994 Mar; 190(3):623-31. PubMed ID: 8115600
[TBL] [Abstract][Full Text] [Related]
32. Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions.
Laws A; Leonard S; Hershey E; Stokes S; Vincuilla J; Sharma E; Milliron K; Garber JE; Merajver SD; King TA; Pilewskie ML
Ann Surg Oncol; 2024 May; 31(5):3120-3127. PubMed ID: 38261128
[TBL] [Abstract][Full Text] [Related]
33. [Lobular carcinoma in situ: the mammographic aspects and the therapeutic problems].
Meloni GB; Becchere MP; Soro D; Profili S; Conti M; Canalis GC
Radiol Med; 1996 Apr; 91(4):360-3. PubMed ID: 8643844
[TBL] [Abstract][Full Text] [Related]
34. Core needle biopsy of synchronous ipsilateral breast lesions: impact on treatment.
Liberman L; Dershaw DD; Rosen PP; Morris EA; Cohen MA; Abramson AF
AJR Am J Roentgenol; 1996 Jun; 166(6):1429-32. PubMed ID: 8633457
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of carcinoma in situ in normal and cancer-associated breasts.
Alpers CE; Wellings SR
Hum Pathol; 1985 Aug; 16(8):796-807. PubMed ID: 2991111
[TBL] [Abstract][Full Text] [Related]
36. Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
Greene AJE; Davis J; Moon J; Dubin I; Cruz A; Gupta M; Moazzez A; Ozao-Choy J; Gupta E; Manchandia T; Kalantari BN; Rahbar G; Dauphine C
Ann Surg Oncol; 2024 May; 31(5):3177-3185. PubMed ID: 38386195
[TBL] [Abstract][Full Text] [Related]
37. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
Huang CY; Chang RF; Lin CY; Hsieh MS; Liao PC; Wang YJ; Kao YC; Porta L; Lin PY; Lee CC; Lee YH
Histopathology; 2024 May; 84(6):983-1002. PubMed ID: 38288642
[TBL] [Abstract][Full Text] [Related]
38. Ductal carcinoma in situ (DCIS): a revised concept.
Gump FE; Jicha DL; Ozello L
Surgery; 1987 Nov; 102(5):790-5. PubMed ID: 2823405
[TBL] [Abstract][Full Text] [Related]
39. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.
Page DL; Kidd TE; Dupont WD; Simpson JF; Rogers LW
Hum Pathol; 1991 Dec; 22(12):1232-9. PubMed ID: 1748429
[TBL] [Abstract][Full Text] [Related]
40. Recurrent carcinoma after breast conservation: diagnosis with stereotaxic core biopsy.
Liberman L; Dershaw DD; Durfee S; Abramson AF; Cohen MA; Hann LE; Rosen PP
Radiology; 1995 Dec; 197(3):735-8. PubMed ID: 7480747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
